Signatures of gene expression, DNA methylation and microRNAs of hepatocellular carcinoma with vascular invasion

被引:11
|
作者
Sulaiman, Siti A. [1 ]
Abu, Nadiah [1 ]
Ab-Mutalib, Nurul-Syakima [1 ]
Low, Teck Yew [1 ]
Jamal, Rahman [1 ]
机构
[1] UKM, UKM Med Mol Biol Inst UMBI, Jalan Yaacob Latiff, Kuala Lumpur 56000, Malaysia
关键词
biomarker; GPD1L; HCC; TCGA; vascular invasion; HYPOXIA-INDUCIBLE FACTOR; MICROVASCULAR INVASION; GROWTH; SUPPRESSION; PREDICTION; RECEPTOR; SYSTEM; KLF4;
D O I
10.2217/fon-2018-0909
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Aim: Micro and macro vascular invasion (VI) are known as independent predictors of tumor recurrence and poor survival after surgical treatment of hepatocellular carcinoma (HCC). Here, we aimed to re-analyze The Cancer Genome Atlas ofliver hepatocellular carcinoma datasets to identify the VI-expression signatures. Materials & methods: We filtered The Cancer Genome Atlas liver hepatocellular carcinoma (LIHC) datasets into three groups: no VI (NVI=198); micro VI (MIVI=89) and macro VI (MAVI=16). We performed differential gene expression, methylation and microRNA analyses. Results & conclusion: We identified 12 differentially expressed genes and 55 differentially methylated genes in MAVI compared with no VI. The GPD1L gene appeared in all of the comparative analyses. Higher GPD1L expression was associated with VI and poor outcomes in the HCC patients.
引用
收藏
页码:2603 / 2617
页数:15
相关论文
共 50 条
  • [31] DNA methyltransferase expression and DNA methylation in human hepatocellular carcinoma and their clinicopathological correlation
    Oh, Bong-Kyeong
    Kim, Haeryoung
    Park, Hye-Jung
    Shim, Yhong-Hee
    Choi, Jinsub
    Park, Chanil
    Park, Young Nyun
    INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2007, 20 (01) : 65 - 73
  • [32] Integrative analysis of DNA methylation and gene expression reveals hepatocellular carcinoma-specific diagnostic biomarkers
    Jinming Cheng
    Dongkai Wei
    Yuan Ji
    Lingli Chen
    Liguang Yang
    Guang Li
    Leilei Wu
    Ting Hou
    Lu Xie
    Guohui Ding
    Hong Li
    Yixue Li
    Genome Medicine, 10
  • [33] Integrative analysis of DNA methylation and gene expression reveals distinct hepatocellular carcinoma subtypes with therapeutic implications
    Huang, Xiaowen
    Yang, Chen
    Wang, Jilin
    Sun, Tiantian
    Xiong, Hua
    AGING-US, 2020, 12 (06): : 4970 - 4995
  • [34] Integrative analysis of DNA methylation and gene expression reveals hepatocellular carcinoma-specific diagnostic biomarkers
    Cheng, Jinming
    Wei, Dongkai
    Ji, Yuan
    Chen, Lingli
    Yang, Liguang
    Li, Guang
    Wu, Leilei
    Hou, Ting
    Xie, Lu
    Ding, Guohui
    Li, Hong
    Li, Yixue
    GENOME MEDICINE, 2018, 10
  • [35] Distinct chromosomal bias of gene expression signatures in the progression of hepatocellular carcinoma
    Midorikawa, Y
    Tsutsumi, S
    Nishimura, K
    Kamimura, N
    Kano, M
    Sakamoto, H
    Makuuchi, M
    Aburatani, H
    CANCER RESEARCH, 2004, 64 (20) : 7263 - 7270
  • [36] Identification of DNA methylation associated gene signatures in endometrial cancer via integrated analysis of DNA methylation and gene expression systematically
    Men, Chuandi
    Chai, Hongjuan
    Song, Xumin
    Li, Yue
    Du, Huawen
    Ren, Qing
    JOURNAL OF GYNECOLOGIC ONCOLOGY, 2017, 28 (06)
  • [37] Gene Signatures in the Management of Hepatocellular Carcinoma
    Hoshida, Yujin
    Moeini, Agrin
    Alsinet, Clara
    Kojima, Kensuke
    Villanueva, Augusta
    SEMINARS IN ONCOLOGY, 2012, 39 (04) : 473 - 485
  • [38] Gene signatures in hepatocellular carcinoma (HCC)
    Andrisani, Ourania M.
    Studach, Leo
    Merle, Philippe
    SEMINARS IN CANCER BIOLOGY, 2011, 21 (01) : 4 - 9
  • [39] CTHRC1 modulates cell proliferation and invasion in hepatocellular carcinoma by DNA methylation
    Sun, Xiangjun
    Liu, Ye
    Cheng, Changdong
    Sun, Haoyu
    Tian, Liqiang
    DISCOVER ONCOLOGY, 2024, 15 (01)
  • [40] DNA methylation biomarkers for hepatocellular carcinoma
    Guorun Fan
    Yaqin Tu
    Cai Chen
    Haiying Sun
    Chidan Wan
    Xiong Cai
    Cancer Cell International, 18